3 FEBRUARY 2005

NEW ZEALAND GAZETTE, No. 32

Aristolochic acid; at all strengths
Atazanavir
Atomoxetine
Atropa belladonna; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram
Atropine; except when specified elsewhere in the Schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram
Atropine methonitrate
Benorylate
Benzocaine; for internal use; for external use in medicines containing more than 10%
Benzydamine; for internal use
Bevacizumab
Bexarotene
Bosentan
Butacaine
Butyl aminobenzoate; except in medicines for dermal use containing 2% or less
Carbetocin
Cinacalcet
Cinchocaine; for ophthalmic use; for external use in medicines containing more than 0.5%
Clindamycin
Colestyramine
Collagen; in injections or implantations for tissue augmentation or cosmetic use
Darbepoetin
Datura spp; except for oral use when specified elsewhere in the Schedule; except in datura stramonium or datura tatula for smoking or burning
Deferiprone
Dextrorphan
Dicyclomine
Digoxin-specific antibody fragment
Diperodon
Drotrecogin
Duboisia leichhardtii; except when specified elsewhere in the Schedule
Duboisia myoporides; except when specified elsewhere in the Schedule
Duloxetine
Efalizumab
Emtricitabine
Enfuvirtide
Eplerenone
Epinastine
Ephedra spp; except ephedra navadensis
Everolimus
Epoetins
Etidocaine
Ezetimibe
Fenofibrate
Fluorides; for internal use except in parenteral nutrition replacement preparations or in medicines containing 2.2 milligrams or less per dose form of sodium fluoride; for external use in medicines other than pastes, gels or powders for cleaning the teeth containing more than 2.5% except when used in practice by a registered dental therapist; except in medicines containing 15 milligrams or less per litre or per kilogram
Folic acid; for injection
Folinic acid; for injection
Gefitinib
Glatiramer acetate
Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram
Guaiphenesin; except for oral use in medicines containing 2% or less or 200 milligrams or less
Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Homatropine
Human protein C
Hyaluronic acid; in injections or implantations for tissue augmentation or cosmetic use
Hydroquinone; except in medicines for external use containing 2% or less
Hylan polymer; in injections or implantations for tissue augmentation or cosmetic use
Hyoscine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in the Schedule
Hyoscyamine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscyamus niger; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram
Hypromellose; for injection except in intraocular viscoelastic products
Ibritumomab tiuxetan
Insulins
Isosorbide dinitrate
Laronidase-rch
Levetiracetam
Levosimendan
Lignocaine; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use except when used in practice by a registered optometrist; for injection except when used as a local anaesthetic in practice by a registered nurse or podiatrist or by a dental therapist; for external use in medicines containing more than 10%
Lumiracoxib
Melagatran
Memantine
Nicoumalone
Nitrofurazone
Norelgestromin
Nux vomica
Oxedrine; in medicines containing more than 30 milligrams per recommended daily dose
Pegfilgrastim
Pemetrexed
Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin